# OnCo record nct07155187 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07155187/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07155187", "NCT07155187" ;
  schema:name "A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer"@en ;
  schema:description "A phase 2/3 trial testing Telisotuzumab adizutecan in non-small-cell lung cancer, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07155187/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07155187> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "2/3" ;
  schema:startDate "2025-12-10" ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/egfr-mutant-nsclc/> ;
  onco:drugs <https://onco.cc/drugs/telisotuzumab-adizutecan/> ;
  onco:companies <https://onco.cc/companies/abbvie/> .